296 related articles for article (PubMed ID: 24056948)
1. Identifying producers of antibacterial compounds by screening for antibiotic resistance.
Thaker MN; Wang W; Spanogiannopoulos P; Waglechner N; King AM; Medina R; Wright GD
Nat Biotechnol; 2013 Oct; 31(10):922-7. PubMed ID: 24056948
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic resistance-mediated isolation of scaffold-specific natural product producers.
Thaker MN; Waglechner N; Wright GD
Nat Protoc; 2014; 9(6):1469-79. PubMed ID: 24874813
[TBL] [Abstract][Full Text] [Related]
3. Phylogenetic reconciliation reveals the natural history of glycopeptide antibiotic biosynthesis and resistance.
Waglechner N; McArthur AG; Wright GD
Nat Microbiol; 2019 Nov; 4(11):1862-1871. PubMed ID: 31406334
[TBL] [Abstract][Full Text] [Related]
4. Harnessing the synthetic capabilities of glycopeptide antibiotic tailoring enzymes: characterization of the UK-68,597 biosynthetic cluster.
Yim G; Kalan L; Koteva K; Thaker MN; Waglechner N; Tang I; Wright GD
Chembiochem; 2014 Nov; 15(17):2613-23. PubMed ID: 25255985
[TBL] [Abstract][Full Text] [Related]
5. Balhimycin, a new glycopeptide antibiotic produced by Amycolatopsis sp. Y-86,21022. Taxonomy, production, isolation and biological activity.
Nadkarni SR; Patel MV; Chatterjee S; Vijayakumar EK; Desikan KR; Blumbach J; Ganguli BN; Limbert M
J Antibiot (Tokyo); 1994 Mar; 47(3):334-41. PubMed ID: 8175486
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles.
Printsevskaya SS; Reznikova MI; Korolev AM; Lapa GB; Olsufyeva EN; Preobrazhenskaya MN; Plattner JJ; Zhang YK
Future Med Chem; 2013 Apr; 5(6):641-52. PubMed ID: 23617428
[TBL] [Abstract][Full Text] [Related]
7. Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms.
Marshall CG; Lessard IA; Park I; Wright GD
Antimicrob Agents Chemother; 1998 Sep; 42(9):2215-20. PubMed ID: 9736537
[TBL] [Abstract][Full Text] [Related]
8. Progress in Understanding the Genetic Information and Biosynthetic Pathways behind Amycolatopsis Antibiotics, with Implications for the Continued Discovery of Novel Drugs.
Chen S; Wu Q; Shen Q; Wang H
Chembiochem; 2016 Jan; 17(2):119-28. PubMed ID: 26503579
[TBL] [Abstract][Full Text] [Related]
9. How To Make a Glycopeptide: A Synthetic Biology Approach To Expand Antibiotic Chemical Diversity.
Yim G; Wang W; Thaker MN; Tan S; Wright GD
ACS Infect Dis; 2016 Sep; 2(9):642-650. PubMed ID: 27759388
[TBL] [Abstract][Full Text] [Related]
10. Renaissance in antibacterial discovery from actinomycetes.
Baltz RH
Curr Opin Pharmacol; 2008 Oct; 8(5):557-63. PubMed ID: 18524678
[TBL] [Abstract][Full Text] [Related]
11. Glycopeptide antibiotics and their novel semi-synthetic derivatives.
Jeya M; Moon HJ; Lee KM; Kim IW; Lee JK
Curr Pharm Biotechnol; 2011 Aug; 12(8):1194-204. PubMed ID: 21470154
[TBL] [Abstract][Full Text] [Related]
12. Genomic-Led Discovery of a Novel Glycopeptide Antibiotic by
Yushchuk O; Vior NM; Andreo-Vidal A; Berini F; Rückert C; Busche T; Binda E; Kalinowski J; Truman AW; Marinelli F
ACS Chem Biol; 2021 May; 16(5):915-928. PubMed ID: 33913701
[TBL] [Abstract][Full Text] [Related]
13. Glycopeptide antibiotic discovery in the genomic era.
Xu M; Wang W; Wright GD
Methods Enzymol; 2022; 665():325-346. PubMed ID: 35379441
[TBL] [Abstract][Full Text] [Related]
14. Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling.
Culp EJ; Waglechner N; Wang W; Fiebig-Comyn AA; Hsu YP; Koteva K; Sychantha D; Coombes BK; Van Nieuwenhze MS; Brun YV; Wright GD
Nature; 2020 Feb; 578(7796):582-587. PubMed ID: 32051588
[TBL] [Abstract][Full Text] [Related]
15. New 4-oxovancosamine-containing glycopeptide antibiotics from Amycolatopsis sp. Y-86,21022.
Vértesy L; Fehlhaber HW; Kogler H; Limbert M
J Antibiot (Tokyo); 1996 Jan; 49(1):115-8. PubMed ID: 8609078
[No Abstract] [Full Text] [Related]
16. [In vitro activity of a new glycopeptide antibiotic eremomycin in relation to obligate anaerobic Gram-positive bacteria].
Malkova IV; Borisova OK; Pavlova MV; Zemlianitskaia EP; Sergeeva TI
Antibiot Khimioter; 1991 Apr; 36(4):17-20. PubMed ID: 1654046
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic Cascade To Evaluate the Tricyclization of Glycopeptide Antibiotic Precursor Peptides as a Prequel to Biosynthetic Redesign.
Tailhades J; Zhao Y; Schoppet M; Greule A; Goode RJA; Schittenhelm RB; De Voss JJ; Cryle MJ
Org Lett; 2019 Nov; 21(21):8635-8640. PubMed ID: 31603691
[TBL] [Abstract][Full Text] [Related]
18. Mutasynthesis of glycopeptide antibiotics: variations of vancomycin's AB-ring amino acid 3,5-dihydroxyphenylglycine.
Weist S; Kittel C; Bischoff D; Bister B; Pfeifer V; Nicholson GJ; Wohlleben W; Süssmuth RD
J Am Chem Soc; 2004 May; 126(19):5942-3. PubMed ID: 15137740
[TBL] [Abstract][Full Text] [Related]
19. [The structure of antibiotic eremomycin B].
Berdnikova TF; Shashkov AS; Katrukha GS; Lapchinskaia OA; Iurkevich NV; Grachev AA; Nifant'ev NE
Bioorg Khim; 2009; 35(4):550-6. PubMed ID: 19928058
[TBL] [Abstract][Full Text] [Related]
20. Glycopeptide antibiotic biosynthesis.
Yim G; Thaker MN; Koteva K; Wright G
J Antibiot (Tokyo); 2014 Jan; 67(1):31-41. PubMed ID: 24220108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
